These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27389348)

  • 1. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder.
    Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.
    Wink LK; Early M; Schaefer T; Pottenger A; Horn P; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):78-82. PubMed ID: 24564519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second-generation antipsychotics.
    de Hoogd S; Overbeek WA; Heerdink ER; Correll CU; de Graeff ER; Staal WG
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):166-73. PubMed ID: 22506734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
    Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
    Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
    JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
    Wink LK; Pedapati EV; Horn PS; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):91-94. PubMed ID: 26465194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
    Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
    Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
    Sochocky N; Milin R
    Curr Clin Pharmacol; 2013 Nov; 8(4):370-9. PubMed ID: 24050741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA
    Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.
    Scahill L; Jeon S; Boorin SJ; McDougle CJ; Aman MG; Dziura J; McCracken JT; Caprio S; Arnold LE; Nicol G; Deng Y; Challa SA; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):415-23. PubMed ID: 27126856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.
    Wink LK; Adams R; Pedapati EV; Dominick KC; Fox E; Buck C; Erickson CA
    J Autism Dev Disord; 2017 Jul; 47(7):2290-2294. PubMed ID: 28447303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.
    Handen BL; Anagnostou E; Aman MG; Sanders KB; Chan J; Hollway JA; Brian J; Arnold LE; Capano L; Williams C; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Peleg N; Odrobina D; McAuliffe-Bellin S; Marler S; Wong T; Wagner A; Hadjiyannakis S; Macklin EA; Veenstra-VanderWeele J
    J Am Acad Child Adolesc Psychiatry; 2017 Oct; 56(10):849-856.e6. PubMed ID: 28942807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole for treating irritability associated with autism spectrum disorders.
    Bartram LA; Lozano J; Coury DL
    Expert Opin Pharmacother; 2019 Aug; 20(12):1421-1427. PubMed ID: 31180743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.